173 related articles for article (PubMed ID: 18660695)
21. [The unexpected occurrence of spontaneous pregnancy during hormone replacement therapy for premature menopause].
Boulieu D; Bully C
J Gynecol Obstet Biol Reprod (Paris); 1993; 22(4):357-60. PubMed ID: 8360432
[TBL] [Abstract][Full Text] [Related]
22. Assessment of ovarian reserve in adult childhood cancer survivors using anti-Müllerian hormone.
Lie Fong S; Laven JS; Hakvoort-Cammel FG; Schipper I; Visser JA; Themmen AP; de Jong FH; van den Heuvel-Eibrink MM
Hum Reprod; 2009 Apr; 24(4):982-90. PubMed ID: 19153092
[TBL] [Abstract][Full Text] [Related]
23. Treatment concepts for premature ovarian failure.
van Kasteren Y
J Soc Gynecol Investig; 2001; 8(1 Suppl Proceedings):S58-9. PubMed ID: 11223376
[TBL] [Abstract][Full Text] [Related]
24. [Poor ovary response to the controlled ovarian hyperstimulation].
Vladimirov IaK; Blagoeva V
Akush Ginekol (Sofiia); 2003; 42(6):25-8. PubMed ID: 15067811
[TBL] [Abstract][Full Text] [Related]
25. Premature ovarian failure.
Meskhi A; Seif MW
Curr Opin Obstet Gynecol; 2006 Aug; 18(4):418-26. PubMed ID: 16794423
[TBL] [Abstract][Full Text] [Related]
26. Resumption of ovarian function 20 years after chemotherapy-induced ovarian failure: a case report.
Longway M; Matthews CA
Fertil Steril; 2009 Jul; 92(1):392.e17-8. PubMed ID: 19403127
[TBL] [Abstract][Full Text] [Related]
27. Pregnancies in patients with POF gonadotropin stimulation and pretreatment with ethinyl estradiol.
Blumenfeld Z
Fertil Steril; 2007 Sep; 88(3):763; author reply 763. PubMed ID: 17681336
[No Abstract] [Full Text] [Related]
28. Mullerian Inhibiting Substance is an ovarian growth factor of emerging clinical significance.
Seifer DB; Maclaughlin DT
Fertil Steril; 2007 Sep; 88(3):539-46. PubMed ID: 17559842
[TBL] [Abstract][Full Text] [Related]
29. Premature ovarian failure: treatment strategies.
Wheeler CA
R I Med; 1995 May; 78(5):130-1. PubMed ID: 7606058
[TBL] [Abstract][Full Text] [Related]
30. Do etiologies of premature ovarian aging (POA) mimic those of premature ovarian failure (POF)?
Gleicher N; Weghofer A; Oktay K; Barad D
Hum Reprod; 2009 Oct; 24(10):2395-400. PubMed ID: 19617205
[TBL] [Abstract][Full Text] [Related]
31. Correlation of triple repeats on the FMR1 (fragile X) gene to ovarian reserve: a new infertility test?
Gleicher N; Weghofer A; Oktay K; Barad DH
Acta Obstet Gynecol Scand; 2009; 88(9):1024-30. PubMed ID: 19642041
[TBL] [Abstract][Full Text] [Related]
32. Ovarian recovery after stem cell transplantation.
Liu J; Malhotra R; Voltarelli J; Stracieri AB; Oliveira L; Simoes BP; Ball ED; Carrier E
Bone Marrow Transplant; 2008 Feb; 41(3):275-8. PubMed ID: 17952128
[TBL] [Abstract][Full Text] [Related]
33. The clinical significance of the retrieval of a low number of oocytes following mild ovarian stimulation for IVF: a meta-analysis.
Verberg MF; Eijkemans MJ; Macklon NS; Heijnen EM; Baart EB; Hohmann FP; Fauser BC; Broekmans FJ
Hum Reprod Update; 2009; 15(1):5-12. PubMed ID: 19091754
[TBL] [Abstract][Full Text] [Related]
34. Autoimmunity and antigenic targets in ovarian pathology.
Forges T; Monnier-Barbarino P; Faure GC; Béné MC
Hum Reprod Update; 2004; 10(2):163-75. PubMed ID: 15073145
[TBL] [Abstract][Full Text] [Related]
35. [Autoimmune precocious menopause: therapeutic consequences].
Fénichel P; Sosset C
Contracept Fertil Sex; 1997; 25(7-8):639-42. PubMed ID: 9410381
[TBL] [Abstract][Full Text] [Related]
36. Choice of hormone replacement therapy in young women with ovarian failure.
Bath LE; Critchley HO; Kelnar CJ; Wallace WH
Clin Endocrinol (Oxf); 2001 Nov; 55(5):697-8. PubMed ID: 11894984
[No Abstract] [Full Text] [Related]
37. Ovarian failure following cancer treatment: current management and quality of life.
Absolom K; Eiser C; Turner L; Ledger W; Ross R; Davies H; Coleman R; Hancock B; Snowden J; Greenfield D;
Hum Reprod; 2008 Nov; 23(11):2506-12. PubMed ID: 18664468
[TBL] [Abstract][Full Text] [Related]
38. Autoimmunity and premature ovarian failure.
Tuohy VK; Altuntas CZ
Curr Opin Obstet Gynecol; 2007 Aug; 19(4):366-9. PubMed ID: 17625420
[TBL] [Abstract][Full Text] [Related]
39. The role of mullerian inhibiting substance in female reproduction.
Nakhuda GS
Curr Opin Obstet Gynecol; 2008 Jun; 20(3):257-64. PubMed ID: 18460940
[TBL] [Abstract][Full Text] [Related]
40. Is the immunological noise of abnormal autoimmunity an independent risk factor for premature ovarian aging?
Gleicher N; Weghofer A; Oktay K; Barad DH
Menopause; 2009; 16(4):760-4. PubMed ID: 19197218
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
